In this article our panel of experts describe the validation strategy for the Growth Direct system for the analysis of environmental samples in a controlled manufacturing environment. The validation strategy used is following the process defined in the PDA TR33 report and in compliance with the pharmacopeia USP <1223> and PhEur 5.1.6.
Fill out the form to get your copy today.